DNA methylation biomarker for cumulative lead exposure is associated with Parkinson’s disease.
Paul, K. C., Horvath, S., Del Rosario, I., Bronstein, J. M., & Ritz, B. (2021). Clinical Epigenetics, 13(1), 1-4.
DNA methylation biomarker for cumulative lead exposure is associated with Parkinson’s disease.
Paul, K. C., Horvath, S., Del Rosario, I., Bronstein, J. M., & Ritz, B. (2021). Clinical Epigenetics, 13(1), 1-4.